Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GLOBUS MEDICAL INC | 7,244,201 | reported | 08 Aug 2012 | tx 3+7,444,168−8,248,400 |
| AVANIR PHARMACEUTICALS | 6,669,216 | reported | 09 Nov 2010 | tx 7−6,990,424 |
| NEORX CORP | 6,363,249 | reported | 09 Nov 2009 | tx 3−494,962 |
| CRITICAL THERAPEUTICS INC | 3,845,876 | reported | 13 Feb 2007 | tx 9+4,314,393−15,780,000 |
| Forty Seven, Inc. | 3,816,951 | reported | 02 Jul 2018 | tx 7+3,816,951−3,616,951 |
| MPM ACQUISITION CORP | 2,459,804 | reported | 27 Sept 2016 | tx 11+3,751,114−1,862,005 |
| SENORX INC | 1,985,875 | reported | 28 Jun 2010 | tx 2−207,893 |
| ARYx Therapeutics, Inc. | 536,313 | reported | 14 Nov 2008 | tx 2+2,324,023 |
| CRYOCOR INC | 53,101 | reported | 24 Apr 2007 | tx 2+149,652 |
| AVEO PHARMACEUTICALS INC | 12,500 | reported | 01 Jun 2011 | tx 8+2,233,961−8,835,860 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Jun 2019 | GRANT_AWARD | Entasis Therapeutics Holdings Inc. | 7,500 | 0.00 USD | deriv |
| 25 Mar 2019 | GRANT_AWARD | NanoString Technologies Inc | 4,410 | 0.00 USD | deriv |
| 18 Jan 2019 | GRANT_AWARD | Entasis Therapeutics Holdings Inc. | 15,000 | 0.00 USD | deriv |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 412,583 | — | |
| 28 Sept 2018 | PURCHASE | Entasis Therapeutics Holdings Inc. | 453,395 | 15.00 USD | |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 361,829 | — | |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 323,341 | — | |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 7,500,000 | 0.00 USD | deriv |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 8,552,024 | 0.00 USD | deriv |
| 28 Sept 2018 | CONVERSION | Entasis Therapeutics Holdings Inc. | 6,702,213 | 0.00 USD | deriv |
| 17 Sept 2018 | EXERCISE | NanoString Technologies Inc | 162,408 | 8.45 USD | |
| 17 Sept 2018 | SALE | NanoString Technologies Inc | 85,823 | 15.99 USD | |
| 17 Sept 2018 | EXERCISE | NanoString Technologies Inc | 162,408 | 0.00 USD | deriv |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 755,780 | — | |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 938,489 | — | |
| 02 Jul 2018 | PURCHASE | Forty Seven, Inc. | 200,000 | 16.00 USD | first after silence |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 1,922,682 | — | |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 1,922,682 | — | deriv |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 938,489 | — | deriv |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 755,780 | — | deriv |
| 01 Jan 2018 | GRANT_AWARD | NanoString Technologies Inc | 10,168 | 0.00 USD | deriv |
| 01 Jan 2017 | GRANT_AWARD | NanoString Technologies Inc | 8,611 | 0.00 USD | deriv |
| 27 Sept 2016 | OTHER | MPM ACQUISITION CORP | 1,229,902 | 0.00 USD | |
| 03 Aug 2016 | GRANT_AWARD | Astria Therapeutics, Inc. | 6,500 | 0.00 USD | deriv |
| 11 Jan 2016 | SALE | Ophthotech Corp. | 1,001 | 66.33 USD |
6 purchases reported after at least 12 months of silence — most recent on 02 Jul 2018.